Sort
30,917 grants matching “tumor microenvironment”
Quantitative assessment of the role of collagen alterations in ovarian cancer
$418,598Paul J. Campagnola · University Of Wisconsin-Madison · R01 · FY2017 · CA
Collagen remodeling and tumor progression
$418,583Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2012 · CA
Project 3: Skin hypoxia, MCPyV infection, and MCC tumorigenesis
$418,564Jianxin You · University Of Pennsylvania · P01 · FY2023 · CA
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma
$418,553Eveline Barbieri · Baylor College Of Medicine · R01 · FY2025 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$418,528Zhen Gu · University Of California Los Angeles · R01 · FY2019 · CA
Role of Inflammation in Tax-mediated Tumorigenesis
$418,523Lee Ratner · Ohio State University · P01 · FY2010 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$418,484Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2025 · CA
Coupling Advanced Computational Analyses for Mammography and SHG Imaging for Early Detection of Breast Cancer Tissue Microenvironment Disruptions Accompanying Tumorigenesis
$418,484Andre Khalil · University Of Maine Orono · R15 · FY2020 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$418,480Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2013 · CA
Targeting pancreatic cancer's metabolic addiction to HuR
$418,473Jordan M Winter · Case Western Reserve University · R37 · FY2024 · CA
Nanotherapeutic treatment of the invasive glioblastoma microenvironment
$418,330Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2020 · NS
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$418,234Melody A Swartz · University Of Chicago · R01 · FY2024 · CA
METALLOPROTEINASES AND MAMMARY GLAND REMODELING
$418,214University Of California San Francisco · R01 · FY2002 · CA
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
$418,181Jason Weber · Washington University · R01 · FY2025 · CA
Tumor and Stromal Metalloproteinases in Breast Cancer
$418,177Lynn M Matrisian · Vanderbilt University · R01 · FY2006 · CA
Project 3: The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis
$418,152Don X Nguyen · Yale University · P50 · FY2025 · CA
Transport Oncophysics Core
$418,062Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$418,039William J Aronson · University Of California Los Angeles · R01 · FY2019 · CA
Light-targeted drug delivery
$418,038Matthew C Hartman · Virginia Commonwealth University · R15 · FY2012 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$417,988Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2022 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$417,987Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2025 · CA
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$417,945David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Functional Activation of Low Affinity TILs
$417,867Jill E Slansky · University Of Colorado Denver · R01 · FY2020 · CA
Cell surface receptor targeted therapies for brain tumors
$417,858Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · CA
Biobehavioral pathways linking stress and cancer progression
$417,819Jennifer L. Steel · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA